 Itamar Medical NASDAQ:ITMR was upgraded by Zacks Investment Research from a hold rating to a buy rating in a note issued to investors on Wednesday, Zacks.com reports. The firm currently has a 21.00 price objective on the stock. Zacks Investment Researchs target price suggests a potential upside of 13.21 from the stocks current price. According ... 